Want to join the conversation?
Pharma company $LLY said that European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has positively recommended the granting of a conditional marketing authorization for olaratumab, in combination with doxorubicin. This drug is used for the treatment of adults with advanced soft tissue sarcoma, a type of cancer.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?